Evidence map›Paper›PMID 39609395›Full record

ArticleNature communications2024

Adaptation in human immune cells residing in tissues at the frontline of infections.

Irepan Salvador-Martínez, Jesus Murga-Moreno, Juan C Nieto, Clara Alsinet, David Enard, Holger Heyn

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Irepan Salvador-Martínez *CNAG, Centro Nacional de Análisis Genómico, Barcelona, Spain.ORCID 0000-0002-3188-9784
Jesus Murga-Moreno *Department of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ, USA.ORCID 0000-0002-1812-0399
Juan C NietoCNAG, Centro Nacional de Análisis Genómico, Barcelona, Spain.ORCID 0000-0002-3400-1488
Clara AlsinetCNAG, Centro Nacional de Análisis Genómico, Barcelona, Spain.ORCID 0000-0002-7779-0667
David EnardDepartment of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ, USA. denard@arizona.edu.ORCID 0000-0003-2634-8016
Holger HeynCNAG, Centro Nacional de Análisis Genómico, Barcelona, Spain. holger.heyn@cnag.eu.ORCID 0000-0002-3276-1889

Funding

Ancient viral threats through the lens of adaptation in human genomesR35GM142677 · NIGMS · UNIVERSITY OF ARIZONA · PI ENARD, DAVID · 2021 to 2025
$1.9M
NIGMS NIH HHS R35 GM142677U.S. Department of Health & Human Services | National Institutes of Health (NIH) NIGMS 5R35GM142677
6 · The paper itself

Abstract

Human immune cells are under constant evolutionary pressure, primarily through their role as first line of defence against pathogens. Most studies on immune adaptation are, however, based on protein-coding genes without considering their cellular context. Here, using data from the Human Cell Atlas, we infer the gene adaptation rate of the human immune landscape at cellular resolution. We find abundant cell types, like progenitor cells during development and adult cells in barrier tissues, to harbour significantly increased adaptation rates. We confirm the adaptation of tissue-resident T and NK cells in the adult lung located in compartments directly facing external challenges, such as respiratory pathogens. Analysing human iPSC-derived macrophages responding to various challenges, we find adaptation in early immune responses. Together, our study suggests host benefits to control pathogen spread at early stages of infection, providing a retrospect of forces that shaped the complexity, architecture, and function of the human body.

Indexed as

Killer Cells, NaturalLungMacrophagesAdaptation, PhysiologicalHumansInduced Pluripotent Stem CellsT-Lymphocytes

Identifiers

PMID39609395
PMCPMC11605006

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.